A normal fibrotic response to inflammatory stimuli appears to be dependent on the balanced production of a number of stimulatory and inhibitory fibroblast-regulatory mediators by activated mononuclear cells (MNL). To investigate whether altered mediator production contributes to the fibrosis observed in progressive systemic sclerosis (PSS), we stimulated human peripheral blood MNL with concanavalin A (Con A) and lipopolysaccharide (LPS) to produce macromolecular mediators that inhibit the proliferation and the collagen production of cultured normal human fibroblasts. The two Con A-induced mediators were lymphokines (LK) as they were exclusively produced by activated T cells and they coeluted from a Sephacryl S-200 column with a Mr of 50,000. In contrast, the two LPS-induced mediators were monokines (MK) as they were exclusively produced by activated monocytes, and they coeluted in the Mr 20,000 range. Each pair of inhibitory LK and MK may also be distinct as inhibition of collagen production still occurred in proliferatively quiescent cultures. A quantitative comparison of the levels of fibroblast-inhibitory LK/MK produced by normal volunteers and long-term PSS patients revealed that although PSS M NL produced normal levels of both collagen product ion inhibitory mediators, they were aberrant producers of both proliferation inhibitory mediators, being hypoproducers (-49 %) of the LK and hyperproducers (+196 %) of the MK. These results suggest that reduced production of proliferation inhibitory LK may allow stimulatory mediators to induce the unrestricted fibroblast proliferation observed in early active PSS, which then may be stabilized in long-term PSS by the increased production of proliferation inhibitory MK.
A normal fibrotic response to inflammatory stimuli appears to be dependent on the balanced production of a number of stimulatory and inhibitory fibroblast-regulatory mediators by activated mononuclear cells (MNL) . To investigate whether altered mediator production contributes to the fibrosis observed in progressive systemic sclerosis (PSS), we stimulated human peripheral blood MNL with concanavalin A (Con A) and lipopolysaccharide (LPS) to produce macromolecular mediators that inhibit the proliferation and the collagen production of cultured normal human fibroblasts. The two Con A-induced mediators were lymphokines (LK) as they were exclusively produced by activated T cells and they coeluted from a Sephacryl S-200 column with a Mr of 50,000. In contrast, the two LPS-induced mediators were monokines (MK) as they were exclusively produced by activated monocytes, and they coeluted in the Mr 20,000 range. Each pair of inhibitory LK and MK may also be distinct as inhibition of collagen production still occurred in proliferatively quiescent cultures. A quantitative comparison of the levels of fibroblast-inhibitory LK/MK produced by normal volunteers and long-term PSS patients revealed that although PSS M NL produced normal levels of both collagen product ion inhibitory mediators, they were aberrant producers of both proliferation inhibitory mediators, being hypoproducers (-49 %) of the LK and hyperproducers (+196 %) of the MK. These results suggest that reduced production of proliferation inhibitory LK may allow stimulatory mediators to induce the unrestricted fibroblast proliferation observed in early active PSS, which then may be stabilized in long-term PSS by the increased production of proliferation inhibitory MK.
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SJ : s timulation index 377 cytes are also associated wi t h an increased fibroblast population a nd t he subsequent fo rmation of fibrotic t issue [1] [2] [3] [4] [5] [6] [7] . This pathologic association of mon onuclear cells (MNL) and fibroblasts in vivo has recently led to the in vitro investigation of the role activated MNL play in producing a normal fibrotic response. A compilation of t hese studies suggests t.hat a normal fibrotic response is t he result of t he carefully balanced production by activated MNL of a number ofT cell-derived lymphokines (LK) and monocyte-derived monokines (MK) with antago nistic fibrobl ast-regu latory activit ies. To date, both LK and MK preparations have been described with activities both as stimulators and as inhibitors of fibroblast movement [8] [9] [10] , proliferation [11 -16) , and protein production, including t he fibrosis forming coll age ns and glycosaminoglycans [17] [18] [19] [20] [21] [22] . H ow the normal balance of stimulatory and inhibitory activities is altered to produce pathologic fibrosis is currently under investigation in a number of inflammation-associated disorders [23, 24] . Progressive systemic scleros is (PSS, scleroderma) is a connective tissue disease of unknown etiology characterized by cuta neous and visceral fibrosis, which during its early stages is associated with extensive MNL infiltration of the t issue sites that later become fibrotic [6, [25] [26] [27] . The MNL infiltrates are composed primarily of T cells and monocytes/ mac rophages, along with s maller numbers of B and plasma cells, and the MNL are acco mpanied by an increased fibroblast population , a portion of which are hyperproducers of collage n [28, 29] . How LK/ MK-mediated mechanisms cont ribu te to increasing fibroblast number and function in vivo in PSS is unknown at present, but it may involve t he unbalanced production of stimulatory and inhibito ry LK/MK by t he T cell and monocyte/ macrophage populations infiltrating the PSS tissue site. While t he T cell s and monocytes/mac rophages present in PSS loci have yet to be functionally classified, studies employi ng peripheral blood MNL indicate t hat PSS is associated both wit h reduced T suppressor ce ll numbers and with increased suppressor monocyte activity [30] [31] [32] [33] [34] . Since aberrant suppressor cell number/ function should logically be accompanied by t he aberrant production of LK/ MK with suppressive or inhibito ry activities, we in t his report have investigated t he production of the LK and MK inhibiting fibroblast proliferation and collagen synthesis by peripheral bl ood MNL from patients with PSS. The reduced production of any of t hese inhibitory LK/ MK would result in a relative excess of t he corresponding stimulatory mediator bei ng present in the PSS loci, which could induce the increased fibrobl ast pro li feration and unregu lated collagen production obse rved in PSS.
In order to be able to discriminately assess t he production of fibrob last-inhibito ry LK/MK in PSS we first optimized the culture conditions necessa ry for the production and assay of LK/ MK supernatants. This enabled us to assay MNL supernatants for fibrobl ast-inhibi to ry activities without in te rference from fibrobl ast-stimulatory activities, as well as to assay LK activity separately from MK activity, and collage n synt hesis inhibitory activity separately from fibroblast prolife ration inhibitory activity. Our res4lts suggest that t he LK and MK inhibiting fibrobla st prolife ration and co llage n production may be 4 distinct factors, and moreove r, in the long-term patients studied , PSS is associated no t onl y with a defi cient production of lhe LK inhibiling fibroblast proliferat ion but also with th e elevated production of the a nalogous MK.
MATERIALS AND METHODS

Patient and No rmal Populations
The patient group co nsisted of 13 fema les ra ngin g in age from 20-75 yea rs (mean , 50.3 yea rs). All pat ients met t he criteri a fo r di agnosis of PSS a nd had a di sease duratio n rangin g from :l-20 yea rs (mean , 9.6 yea rs) . The pa t ient group included both t hose wh o di splayed PSS with diffu se scleroderm a a nd those wit h P SS with t he CREST sy ndrome [:J5 j. No ne of th e patients was receiving co rticosteroids, D-peni cill amin e, or cytotox ic d ru gs at t he t im e of ve nipuncture. Info rmed co nse nt was obta ined fro m all pat ients a nd t hese studi es we re approved by th e Mount S in ai Sc hoo l of Medi cin e Huma n Subj ects Co mmi ttee . The norm a l co nt rol group co nsisted of 14 healthy vo lun tee rs a nd hospital perso nn el, and in cluded l 0 females a nd 4 mal es rangin g in age from 24 -58 yea rs (m ea n, 36.2 yea rs).
Preparation of M N L
All procedures used to prepare MNL a nd to ge nerate LK / M K supern ata nts were perfo rmed wit h medi a a nd reage nts judged to co nta in Jess t han 0.07 ng/ ml endotox in by t.he Limulus a mebocyte lysate assay (MA Bioprodu cts, Walkersville, Maryla nd ). Huma n periph eral hlood MNL were recove red by Fico ll -1-l ypaque fra ction atio n (Fico iiPaq ue, Pha rm ac ia, Piscataway, New J ersey) of buffy coat fractio ns of fres hly drawn hepa rini zed blood 136]. P latelets were routinely removed by ce nt rifugation at 60 g in H a nks' ba la nced salt so lu tio ns (HBSS) (MA Bioproducts) o r in so me cases by sucrose gradi ent ce ntrifu ga ti on [37) . T he resulta nt MNL pell et was resuspended in Du lbecco's minimum esse nt ial medium co ntaining 25 mM HEPES a nd 2 mM gluta min e (DMEM-HEPES) (MA Bi oproducts) plus oth er suppl ements as desc ribed below.
Preparation of Adherent M onocy tes and Enriched T Cells
These enri ched MNL fra ctions were prepa red as prev iously desc ribed 1:38 1. Bri efl y, suspensions of 1 x 10 7 MNL/ ml in DMEM -HEPES plu~ 10% hum a n AB se rum (MA Bioprodu cts) were in cubated at 37"C , fo r J h in t issue cul t ure di s hes or fl as ks (Falco n, Oxnard , Ca li forn ia) in a humi di fi ed atmosphere of 5% CO". No nad herent. ce ll s were removed by washin g the culture vesse ls 6 tim es with 37"C DMEM-HEPES co nta ining 5% human AB se rum . The resul ta nt. adh erent rn onolaye rs co nsisted of > 95 % monocytes HS determined by a-nap hthyl-es terase staining 139 ]. E nri ched T ce ll s were prepared from t he nonadh erent fraction by E-rose tt.in g wit h shee p eryt hrocytes by a prev iously desc ribed rapid E-rosettin g tec hni que j 40 j. Lys is of sheep erythrocyte by hypotoni c sa lin e shoc k foll owed by reroselt.in g of t he rose tte-positi ve pop ul atio n yieldeo:d rosett.e-pos iti ve T -cell populations co nta ining <2% monocytes.
Production of LJ</ M /( Co nl ainin~t Supe rnatants
Freshly prepa red total MNL or enri ched T ce ll" were in cubated at a co nce nt ration of 1 x 10" ce lls/ rnl in DMEM -HEPES supplemented with 0.5 % hum a n se rum albumin (HSA) (New Yo rk Blood Center, New Yo rk , New York ) in t he prese nce of (a) no stimulant, (b) 12.5 11g/ ml co nca nava lin A (Co n A) (S igma, St. Loui s, Mi ssouri ), or {c) 20 ng o r 20 11 g/m llipopolysaccha ride (LPS) (E. coli 01 28:Bl 2, Sigma) at 37"C in a 5% COt at mosphere. Ce ll -free supern atants were co ll ected by ce nt rifugation a fter 24 and 72 h of in cubation. MNL viabili ty at th ese Limes was always greater t ha n 80% as assessed by t rypan blue exclu sio n. La rge-scale prod ucti on was done in 40 -m l vo lu mes in 75-cm" culture fl asks, whil e supern ata nts used in qua nt itative co mpa ri so ns were ge nerated in 5-ml volumes in 35-mm ti ssue cul t ure di shes (ce ll density or 5 x 10''/cm 2 surface a rea) . Monocyte mon olayers used to produ ce supernata nts we re prepared by ad herin g tota l MNL at a ce ll density of 5 x 10''/cm" to t he sa me culture vesse ls and in cubatin g as desc ribed above. Appropriate co nce ntrations of Co n A a nd LPS were add ed to un stimulated cul ture supern ata nts immediately a fte r ha rvestin g and t hese se rved as co nt rol supern ata nts. Ha rvested supern atants were t hen placed in boil ed di a lys is t ubin g (1 2,000-M , cut ofT), and dial yzed at 4•c against a total of 10 9 volumes of di still ed water and a subsequent 10 vo lu mes of fres h DMEM before bein g coll ected, membra ne fil tered, and stored at -70"C until assayed fo r activity. Because th e co ncentrati on of Co n A in t he ge nerated supernatants was found to ha ve an inhibi to ry effec t o n all 3 assays of fibrobl ast fun cti on, a ll Con Aco nta ining superna ta nts were assayed in t he prese nce of 25 mM amet hyi-D-ma nn oside (Sigm a ), wh ich selective ly bl oc ked t.he inhibi to ry Vol. 83, No.5 effect of Co n A whi le havin g no effect. on co nt rol cultures. LPS by itse l f had no effect. on the assayed fibroblast fun ctions. Howeve r, ce rta in lots of HSA we re found t.o stimul ate fibrobl ast proliferation, a nd thus t h e lots of l-I SA we re sc ree ned prio r to use and only lots without prolife rative activity were used in th e ge nerat ion of superna ta nts.
Fibrobla:;t Cultures
P rim ary ce ll cul t ures were established from sectio ned skin ex p la n ts ta ken from th e forea rm s of no rm al adult vo lun tee rs as previou s ly desc ribed 129 1. The fibr ob lasts were grow n to co nfluency in H a m 's FlO medium containing peni cillin (100 U / ml) , streptomyc in (100 p g/ ml ), glu ta min e (2 mM) , NaH CO,. (1.87 mg/ml) , a nd 10% heat -inactivated feta l calf serum (FCS) (Flow Labs, McLea n, Vi rginia) a n d subcultured after trypsini zatio n. The fibr oblasts used to assess LK/ MK activ ity in this study were grown from th e papilla ry sectio n of t h e dermi s and were used betwee n the 4Lh a nd 15th passages.
A :;say for LJ(/ M J< A ctivity Stimula ting Fibrvblast Proliferation
Assay of fibr oblast proliferative activity was perfo rm ed in th e a bse nce of F CS usin g subco nflu ent fibrobl ast mi crocultures (Microtest III -Falco n , 3072) in order to optimize assay se nsit ivity to proliferatio n stimulatin g signals. Fres hly trypsini zed fibr obl asts were fir st plated at 3000 fibrobl asts per mi crowell in 100 11J of DMEM + 10 % F CS fo r 18 h at 37"C in a 5% C0 2 atmosphere to permit adherence to mi crowell bottoms. Cultures were t hen washed with HBSS and in cubated without FCS for 48 h in 100 111 fr es h DMEM + 0.5% bov ine se rum a lbum in (BSA) (S igma) to all ow the fibrob last to ac hi eve proliferative quiesce ncy. The media was t hen removed and replaced with 200 11l of fresh DMEM + 0.5% BSA co nta ining va rious dilutions of MNL supernatants or ge l filtra tio n fractions a nd in cuba ted for a n addi tio nal 48 h. Cultures we re pulsed with 0.5 11Ci ["Hj t hymidine (20 Ci/ mmo l, New En gla nd Nuclea r, Bosto n, Massac huse tts) fo r the las t 24 h of in cubation, and t he in co rporatio n of I"H]th ymidine into DNA was assessed usin a methods simila r to those prev iously reported 111-14]. Briefly, fo ll ow in~ medi a aspiration , cultures were t rypsini zed , harvested onto glass fiber lil t.ers usin g an automated harvest, lysed by was hin g with distilled water, and t he ["H]thymidine-labe led DNA trapped by t he glas fiber filters co unted usin g liquid sc in t ill ation spectrometry. All sample djlu tions were assayed in tripli cate and medi a co nt rol cultures co nt.a inin a no MNL supernata nt cha racteri stically gave mean va lues for I"H J thymidine inco rpora ti on of 800-1200 cpm.
Assay for LJ(/ M /( Act1:vit.y In hibiting Fibroblast Proliferation
Assay of fibrobl ast-growth inhibi tory activity was performed usin g microc ul ture techniques as desc ribed for t he stimulation of proliferatio n assay. Howeve r, a fter 18 h adherence, medi a was removed a n d t hen dilu t ions of MNL supern atants o r column fractio ns in 200 11l fresh DMEM + 10% FCS were added to the fibrob last cultures fo r 24 h a long with 0.5 11 Ci of ["H]thyrnidine. After 24 h in cubat io n !lbroblasts were harvested a nd ["H !t hymidine in co rporation qu ant itated as befo re. Media co ntrol cultures co ntaining no MNL supern ata nt gave means of app rox ima te ly 10,000 cp m (fi broblast. growth induced by FCS).
A ssay for LJ</ M J< Activity I nh ibitin.g Fibrobla st Collagen Production
Assay of co ll age n production was perform ed usin g fibrobla st mi crocul t ures of ident ica l co nditio n a nd duration as those used to measure stimulat ion of proliferation exce pt th at. 12,000 fibrobl as ts were plated per well to produ ce a confluent mon olaye r. The med ia used in plating and culturin g t hese monolaye rs was addjtionally suppl emented with 50 pg/ml asco rbic ac id a nd t he cultures were pulsed with 1.0 1• Ci of [ 3 H ] proline (5 Ci/ mm ol, New England Nuclea r) in th e prese nce of 50 pg/ ml of {:i-aminopropi onitrile for th e te rmin a l 24 h of culture. The in clu sion of [:1-aminop ropi oni t.ri le ensures that t he maj ori ty of co ll agen produced will be sec reted into t he cul ture media 141) . Determin ation of l"H]proline in co rpo ration in to co llage n was performed usin g methods similar to t hose prev iously desc ribed [42 ) . Brieny, t he ext race llular I"H]proline-labeled co llagen was extracted by t he addi t ion of acetic ac id -pepsin to t.h e culture medi a in eac h mi crowell and purified by successive sa lt precipitations at ac id a nd neut ra l pH. The fin al washed prec ipi tate was solubilized in 0.5 M acetic acid, inco rporated in to a sc in ti llatio n coc kta il , and counted in a liquid scintillation coun ter. Media co ntrol cultures co nta ining no MNL supern ata nt gave mea ns of 1000-1500 cpm . This assay was done in 0.5% BSA instead of FCS and at co nf.luency in o rder t.o be a bl e to assess t.he effect of LK/ Ml.; co ntaining sa mples o n co ll agen production in t he abse nce of their effects on fibrobl ast proLiferation.
Quantitativi' Comparison of LK/ M /(Containing Supernatant.s
Log-linear di luti on analys is was used to eva luate the LK / MI< activ· ity produced un der different cu lture co nditions and to quantitative ly compare the levels of LI< / MK produced by norm al vo lun teers and PSS patients. Linear reg re~sion lines we re gene rated for each LK/ MK supe rnatant by first. assayin g in t ripli cate the ["Hjthymidine or ["HJ prolin e incorporAtion induced by a se ri es of !i 3-fold dilutions (1:1.7 to 1:135) of each supe rn ata nt and then plotting the mea n l"H ]thymidine / pro lin e data agai nst. t he log Ill of each of t.he 5 dilutions. For the inhibiti on assays supernatant activit y was compared at the dilution ca usin g 50 % inhibition (10,, 0 ) of t he co un ts obta in ed in medi a co ntrol cu ltures without supern atant , wh ile LK / MK sup ern atants stimul ating pro li feration we re compared <J t the dilution ca using a .')00 % st imulat ion (SD5oo ) ove r med ia co ntrols, and results are presented as the 10,, 0 or SD,00. The compariso n of the LK / MK levels produced by a series of norma l vo lun tee rs and PSS pHtients was further sta nd ardized by comparing t he regression lin e for eac h LI< / MK supern atant to that ge n· era ted by n sta nda rd supern at-a nt obtai ned from the MNL of 1 norm al donor. The standard supernatants were always produced, processed, and assayed simul ta neously wit h each group of norm al or PSS super· natants tested. Based on the 1Dr. 0 and SD,,x, the standard supernata nts were arbitrari ly asss i~ned a value of 1.0 unit / ml and the levels of LI< / MK in the ot her te t.ed supern ata nt s are ex pressed as relative uni ts/ ml.
Gel Filtration Chromatography of Lf(j J\11/( Supernatants
Fifty milliliters of ex haustively dialyzed Ll</MI< supernata nt was conce n t rated to dryness by lyop hi liza tion and redi ssolved in 2 ml of sterile 0.0 l M sodium phosp hate-bu ffered sa line, ph 7.4 (PBS). This co nce ntrated amp le was appl ied to a column (diameter 1.6 em , length 95 e m) t hat was pac ked with Sephac.v l S-200 (P harmacia). The samples were e luted with PBS co nta inin g .01 % polyethylene glycol GOOO against gravity at a fl ow ra te of 10 ml/ h. Fractions of 5.0 ml were co llected and tested fo r activity wit hout further processing. All chromatograp hic procedures were performed at 4 "C.
RESULTS
Stimulation of MNL to Produce Fibroblast-!nhibitol)' LK/MK Supernatants
In order to be able to assess the effect of fibroblast-inhibitory LK/MK o n fibroblast function without interfere nce fr om t he presence of contamin ating fibroblas t-stimulatory factors, we attempted to estab lish MNL culture co ndi t ions t hat would allow t h e production of LK/MK supernatants that excl us ively inhibited fibroblast pro liferation and coll age n production. Preliminary investigation s indi cated t his could best be done by stimul ati ng MNL with LPS to produce MK supernatan ts and with Con A to produce LK supernata nts us ing t he culture conditions described in Materials and Methods. HSA was chosen as the medi a supple me nt for LK/ MK production instead of se rum because H SA maintained the metabolic integrity of the MNL whil e havin g no effect on fibroblast proliferation or collagen production, which greatly simpli fied the interpretation of t h e subsequent assays of supernatant activity on fibroblast functions. The results as prese nted in Table I show t hat MNL stim ulated with eith er 20 11g/ ml LPS or 12.5 ll·g/ml Con A produced supernatants that inhibited both FCS-driven fibroblast proliferation and t he extracellular co llagen production occur ring in confluent proliferatively quiescent fibroblast cu lt ures. The production of both inhibitory factors was timedependent and was at a maximum after 72 h of cu lture. In ge nera l the activity of LPS-induced supernatants was greater than Con A-induced supernatan ts a nd the inhibition of proliferation ca used by both factors was gene ra lly greater than their inhibitio n of collage n production. U nder the assay conditions employed, no LPS-or Con A-induced supernatants stimulated coll age n production nor did Con A-induced supernatants stimulate fibrob last proliferation sign ifica ntly more than did control supernatants. However LPS-induced supernatants did significant ly stimulate fibroblast proliferation, with 24-h supernata nts being more potent t han supernatan t ge nerated for 72 h, which is likely due to t he in creased production of inhibi tory factors after 72 h of culture. Th us we were able to generate Con A-induced LK supernatants t hat exclusively inhibited fibroblast proliferation and collagen production but our LPS-induced MK supern ata nts were contam inated with activity stimul ating fibroblast proliferation. However, further preliminary investigations revealed t hat MNL stimulated with low concentrations of LPS (Table 1-20 ng/ml LPS) produced supernata nts t hat stimulated fibroblast proliferation but did not inhibit fibroblast proliferation or collagen production . Such supernata nts conta ined maximum proliferation-stimulating activity after only 24 h of cu lture and moreover the amoun t of activity was similar to t hat found in 24-h supernatants induced with 20 11g/ ml LPS. This observation made it possible to independently assess t he proliferation-stimulating componen t contaminating our LPS-induced fibrobl ast-in hibito ry MK supernatants. Table I a lso illustrates that supernatants from unstimu lated MNL contain on ly minimal activity in a ll 3 of our fibroblast assays. It should be noted t hat this is true only if endotoxinfree media a nd supplements are used, as endotoxin contamination as low as 0.1 n g/m l induced t he production of supernata n ts t hat stimulated fibroblast proliferation (data not shown). Such endotoxin co ntamin atio n may be responsible for the previously reported spontaneous production of some fibroblastregulatory factors [1 3, 16,21,41 ] as has been reported fo r other MK [43 ] . Minor platelet co ntam in ation had no effect on t he activity of ge nerated supern atants as supernatants produced by MNL tota lly dep leted of pl atelets by sucrose gradient centrifugation had t he sa me levels of activity as did supernatants produced by MNL depleted of platelets by centrifugation in HBSS at 60 g (not shown). b Supernatant di lution inducing a 500% increase ove r media co ntrols. ' Maxim um stimul ation index (cpm supernata nt/cpm med ia co ntrol) induced by a 1:1.7 superna ta nt dilution. a Supernatant dil ution inducing a 50 % dec rease from medi a co ntrols. ' Maximu m inhibition index (cpm supernat.ant/cpm media co ntrol) induced by a 1:1.7 supern atant dilution. In order to insure t hat ["H ) thymidine in corporat ion is a true co rrelate of fibroblast growth as has been reported by others [11, 13, 14] , we studied the effect of LK/MK supernatants on fibrob last pro liferation by continuously culturing subconf1uent fibroblasts in fresh-daily 1:2 di lut ions of supernatant for 6 days and t hen cou nting t he resu ltant cell popu lation . Such experiments showed that fibroblasts grown in 72-h LPS (20 11g/ml) or Con A-induced supernata nts co nta in ed only on e-ha lf to onequarter as many cells as cultures grow n in 10% FCS. The LK/ MK-treated fibrob lasts were sti ll viab le as judged by trypan blue exclusion and t hus at t hese concentrations fibrob last inhibitory LK/MK appear to be cytostatic rather t han cytotox ic.
F ibrob lasts cult ured in 24-h LPS (20 ng/ ml) -induced supernata nts for 6 days contained tw ice as many cells as t hose cul tured in DMEM-BSA a lone (data not shown). Thus our ["H ]t hym idine incorporat ion assay is a true corre late of fibroblast growth.
Wh ile the ["H)proline incorporation assay specifi cally measures t he newly formed collage n in fibroblast microcu lt ures [ 42] , it does not reveal how the LK/MK supernata nts are inhibiting collagen production. T he LK/MK supernatants may actuall y be inhibit ing collage n synthesis as suggested by others [21, 22] or, alternative ly, they may be stimulating intracellular degradation of newly form ed coll agen or simply decreasin g t he in tracellul ar pro li ne poo l size.
Production of Fib roblast-Inhibito1y LK/ MK S upernatants by Monocy tes and T Cells
In order to confirm t hat total MNL produce supernatants containing predomi nately fibrobl ast-active MK when stimulated with LPS and LK when stimulated with Con A, it was necessary to fractionate MNL in to ad herent monocytes a nd Erosette-positive T cells. T he enriched mo nocytes and T cells were t hen stimu lated wit h LPS and Con A and t he supernatants ge nerated assayed for activity as desc ribed in Materials and Methods. T he resul ts reported in Table II indicate t hat active supernatants were ge nerated on ly by LPS-stimulated monocytes or by Con A-stimulated T cell s. Stimulation of T ce lls wit h LPS or monocytes with Con A produced supernatants with only minimal activity. Cons istent with previous reports of endotoxin contamination of some preparations ofT -cell mitoge ns [44] , we fo und some lots of Con A co ntained endotoxin contam ination a nd t he use of such lots erroneously demonstrated stimul ation of MK production by Con A (data not shown). Such endotoxin contamination may a lso be responsible for previously reported production of fibroblast-proliferat ion regul atory factors by monocytes after PHA or Con A stimulation [16, 45] . Table II also s hows t hat Con A-stimulated T cell s produced supernatants t hat exclusively inhibited fibroblast proliferation and collage n production at t he same times as Con Astimulated total MNL. Likewise, monocytes stimulated with either high or low concent rations of LPS produced supernatants with t he same activities and at t he same times as did t he 24 or 74 h on proliferatio n and collagen production of flbrob la ts cul tured usin g th e co nditions listed for the inhibition of collagen production assay.
''Supernatants were tested at a dilution of 1:1.7. ' Values listed are triplicate mea ns ± SO of cpm inco rporated.
LPS stimulation of total MNL. Thus, with our cult ure co nditions, it appears t hat LPS stimul ation of total MNL results in fibroblast-regulatory MK production , while Con A stimulation results in LK generation.
Fib roblast-Inhibitory LK/ MK Supernatants Inhibit Collagen Production Without Inhib iting Fibroblast Proliferation
Since our collagen production assay employed t he use of quiescent conf1uent fibroblast cul tures we were able to assess t he effect of fibroblast-inh ibi to ry LK/MK supernatants on coll age n production in t he absence of their effects on fib roblast proliferation. Data in Table III illustrate t hat both LPS-induced inhibitory MK supernatants a nd Con A-induced inhibitory LK supernata nts inhibited collagen production independently of inhibitio n of fibroblast proliferation. Thus the MK and LK inhibiting collage n production likely act t hrough mechani sms unrelated to tibroblast proliferation, which suggests that t he factors inhibit ing collage n production may be distinct molec ules from those inhibi t ing proliferation.
Gel Filtration Chromatography of Fibroblast-Inhibitory LK/ MK S upernatants
To obtain estimates of t he M , of the monocyte-and T cellderived factors inhibit ing fibroblast proliferation and collagen production, LK/MK supernatants were chromatographed on a Sep hacryl S-200 column. Chromatography of LK supernatant produced by total MNL stimulated for 72 h with 12.5 llg/ ml Con A eluted a broad peak of activity inhibiting fi broblast proliferation in t he M,. range centering a round 50,000 (Fig 1) . In contrast, t he MK inhibiting fibroblast proliferation obtained by 72-h stimulation of total MNL with 20 11g/ml of LPS, eluted in a peak cente red around M, 20,000 (Fig 1) . The elutio n of activ i ty that inhibi ted collagen production pa ralleled t hat which inhibi ted fibroblast proliferation wi th t he majori ty of Con A -induced coll age n -inhibitin g activity co ntained in theM, 50,000 r ange and t he LPS-induced activ ity inhibit ing collage n produ ction in th e M, 20,000 ra nge (data not shown ). Both inh ibi tory activit ies co ntain ed in the Con A-induced supern atan t were tota lly recovered in t he M , 50,000 peak but the M, 20,000 pea k co nta ined less t han 50 % of the applied LPSindu ced activit ies. Loss of activity in t he M , 20,000 range may be d u e to nonspecific adso rp tion to polystyrene collection tubes, an occ urrence which -would be prevented by coelut ion of H SA in t h e M, 50,000 ra nge. The inhibitory activities of t he M, 50,000 pea k fraction we re not due to t he concent ration of HSA presen t n or were t hey due to t he possible presence of eluted Con A dimer, as t he activity of t hese fractions was unaffected by con centrations of a -methyi-D-mannoside from 25-100 mM (data n ot s hown).
--~~~-----~--------~~~~,-------------~---
T h e c hromatographic data fur ther demonstrate that stimulatio n of total MN L wit h Con A and LP S preferent ially produced LK and MK, respecti vely. Con A supernata nts co nta ined only Mr 5 0,000 LK inhibitors and no M, 20,000 MK inhibito rs, while LPS supernatants we re only minim all y contaminated with L K inhibitors of M , 50,000. Thus, alt hough supern atants fro m Con A-stimulated total MNL have been reported to con tain certa in immun oregulatory MK as a resul t of LKtrigger e d production [ 46] , t his appears not to be t he case for these fib r obl ast-inhibitory LK/ MK.
Aberrant Production of the LK and MK Inhibiting Fibroblast Prolife r ation by MNL of PSS Patients
Sin ce L K/ MK production is kn own to in volve t he in terac tion of diffe r e n t MNL subsets through a LK/ MK cascade mechanis m [ 46 ] , we chose to investigate t he levels of fibroblastinh ibitory LK and MK produced by PSS patients using total MNL rather than enric hed popu lations in order t.o optim ize our chances of detecting a defect in LK/ MK production. Total MNL from a series of normal volu nteers and PSS patients were stim ulated with: (a) 20 ng/ ml LPS for 24 h to produce supernatants contain ing exclusively pro liferation stimulatory MK; (b) 20 11g/ ml LPS for 72 h to produce prol iferation / collagen productio n inhi bitory MK; and (c) 12.5 ,ug/ ml Con A for 72 h to produce exclusively proliferation/ collagen production inh ibitory LK. The potency of each generated supernatant was compa ratively qua ntitated and expressed as units/ ml as desc ri bed in Maten:als and Methods. The results presented in Fig 2 s how t hat MNL from the series of PSS patients produced signi fica ntly less t han normal amounts of t he Con A-induced LK t hat inh ibits fibrob last proli feration. The 14 normal volun teers produced 1.01 ± .22 (SD) uni ts/ ml of t he factor while t he 13 PSS pati.ents produced only 0.51 ± .29 units/ ml (p < .001 by two-tailed Student's t-test). If only t he 11 of 13 PSS patients outs ide 2 SD of the norma l mean are considered, the ave rage is 0.4 1 ± .16 uni ts/m l (p < .00 1). T hus it is evident that PSS patients produced fibroblast pro liferation inhibito ry LK in levels markedly lower than cont rols. T h is, however, was not true for the co llagen production inhi bitory LK as Fig 3 shows that the levels of this facto r produced by normal vo luntee rs (1.02 ± .36 uni ts/ml) and PSS patients (1.06 ± .30 units/ ml) to be simil ar. T his observation further suggests t hat t he 2 fibroblast-inhibitory LK are sep arate molecules.
Data illustrated in Fig 2 also show that MNL from PSS patients produced markedly elevated levels of the LPS-induced MK t hat inhibits fibroblast pro liferation. No rmal volunteers produced an ave rage of 1. 15 ± .31 uni ts/ml while PSS patients produced 2.96 ± 1.46 units/ml (p < .001). The 9 of 13 PSS patients producing levels greater t han 2 normal SD averaO'ed 3.83 ± .66 uni ts/ml (p < .001) and all 9 of t hese patients w~re ...
Compa rative productio n of t he MK a nd LK in hibiti ng-fi broblast. p roli feratio n by tota l MNL of norm al voluntee rs and PSS patie nts. MK supe rn ata n ts we re produced by stimulation wit h 20 l'g/ ml LPS fo r 72 h and LK supe rn atants by sti mul ation wi t h 12.5 l'g/ ml Co n A for 72 h. Inhi bito ry activity w as qua nt,itated as desc ribed in Mat erials and Methods a nd ex pressed as uni ts/ ml. T he longer horizontal dashed bars indicate t he ove ra ll mea ns of each group whil e t he shorter horizontal das hed bars indicate t he mea ns of t hose PSS va lues outside 2 SD of the norma l mea ns. Thus PSS patients tru ly produced increased leve ls of the fibroblast proliferat ion-i nhi bito ry MK. T hey did so whi le producing normal amou nts of t he coll agen production inhibi tory MK, as detailed in F ig 3 (norm a l 1.12 ± .29 un its/m l; PSS 1.10 ± .21 uni ts/ml ). T hi s latte r observation suggests that the MK inhibitin g fibrob last prolifera t ion may be different from t he MK inhibit in g coll agen production.
DISCUSSION
T he studies described here were undertaken to evaluate t he capac ity of normal peripheral blood MNL to produced LK and MK inh ibit in g fibr oblast proliferation and coll agen production, and to subsequently co mpare t he normal levels produced wit h those ge nerated by MNL fr om PSS patients. Our resu lts indicate t hat normal MNL stimul ated with Con A produce T cellderi ved LK supernatants t hai excl usively inhibit fibrobl ast proli feration and coll age n prod uction (Tables I, II) . The proliferation -inhibito ry LK may be a distinct molecu le from that inhibit ing co ll agen production as inhibition of coll age n production was demo nstrated in t he absence of effects on proli feration (Table Ill) . However both the proliferation-and co ll age ninhibi ting activit ies coelu ted in theM, 50,000 range on Sephacryl S-200 chromatography (F ig 1) . T his M , estimate is in agreemen t with t hose previously publi shed for both LK-inhibito ry activities [1 5,21 ] . Why LK activity stimu latin g fibrobla st proliferation or collage n production could not be detected in our Co n A-induced supernatants was not in vestigated. The absence, however, may be due to t he fa ct t hat only minimal production of stimulatory LK occurs at t he low MNL density (5 x 10''/c m" surface a rea ) used in our generation cul tures, as t hose reportin g ge neration of stimulatory LK have used eit her high density su rface cul tu res (4 X 10"/cm 1 ) or t he even hi gher density grav ity sedimented pe ll ets t hat form during t ube cul tu re ge neration [11, 12, 17] .
Supernata nts inh ibiting both fibrob last proli feration a nd Vol. 83, No. 5 collage n production were also produced by st im ulating normal MNL with 20 J. Lg/m l LPS (Table 1) . Whi le t hese supernatan ts were shown to contain exclusive ly monocyte-deri ved products (Table II) , t hey also contained a fibroblast proliferation stimul atory MK which could also be produced in the absence of inhibitory MK by stimul ating MNL with only 20 ng/ ml LPS ( Tables I , II) . T he collage n production inhibitory MK was active in t he absence of effects on proliferation (Tab le III) a nd both MK inhibito ry activit ies coelu ted from a Sephac ryl S-200 column in t he M, 20,000 range, further suggesting t hat t h e inhibitory MK are molecu les distinct from t he inhibitory LK. Th is repo rt represents t he first estimation of the M , of t h e LPS-induced MK inhibiting fibrob last proli fe ration a nd collagen production, although 2 previous studies have estimated the M, of spontaneously produced (e ndotoxin conta mination induced?) MK t hat inhibit growth and/or collage n production by inducing prostaglandin sy nt hesis at 12,000-20,000 [16] a nd 20,000-30,000 [22 ] . However, the mechanism of action of t he fibroblast-inhibitory LK and MK described in this report, and t heir re lation to kn own immunoregulato ry LK/MK remain open to speculation until t hey have been more extensive ly characterized as to t heir cellular sources and biochemical properties, although several immunosupp ressive LK/MK with M , similar to our fibroblastinh ibitory facto rs, including the in terfero ns (47] and t he soluble immune response suppressors (48] ex hibit an t iproliferative activity on cell s of nonimmune ori gin . However, in some other instances t he coidentity of fibroblast-regu latory LK/MK and immunoregu latory LK/MK has been proved. Evidence h as bee n prese nted identifying fibronecti n as t he macrop hage-deri ved fibroblast chemotactic factor and hu man monocyte-deri ved fibroblast proli fe ration sti mulatory activity can be attributed to interleukin 1 [9 ,14] . Co nversely, studies in guinea pigs indicate that T ce ll-derived llbroblast proliferation stimulatin g activity is distinct from inte rl eukin 1 [1 2] and human T cellderived fibrob last prolife ration inhibition factor appears to be distinct from a-lymphotoxin [1 5].
Recent studies indicated that pathologic fibrosis is accompa nied by LK/MK production in vivo, as activated monocytesj macroph ages and activated T cells t hat spontaneously produce fibrob last growth factors have been iso lated from t he fibro t ic synovium of rheumatoid art hritis patients and from t he lungs of patients with idiopathic pulmonary fibrosis [23, 24 ] . In vivo LK/MK production in PSS is suggested by t he presence ofTcell blasts among the infi lt rating MNL in affected tissue sites (6] and by the prese nce of factors with LK/ MK activity (fibrobl ast proliferation stimulation, collagen production stimulation, and proliferation inhibition) in t he se rum of PSS pat ients [49] [50] [51] . While t hese studies verify that in vivo "auto-ant ige n " activation ofT cells and monocytes/macrophages results in t h e production of fibrob last-regu lato ry LK/ MK, t hey do not ind.icate whether t he normal balance of stimulato ry and inhibitory LK/MK is altered in cases of pathologic fibros is.
In contrast, t he resul ts of our in vitro study reveal t hat peripheral bl ood MNL from patients with PSS in addition to hav ing a diminished capacity to produce the LK inhibiting fibroblast prolife ration , also possess t he enhanced capacity to produce t he a nalogous MK (Fig 2) . T he aberrant production of these 2 fibroblast proliferation inhibitory facto rs occurred in 9 of 13 PSS patients studied. This characteristic PSS LK/MK production was independent of age as patients of all ages, including one 20-year-old and one 75 -year-old, exhibited t his aberrant production pattern. Whether t his aberrant LK/MK production occurs only in PSS or is also characteristic of other chronic fibrotic di seases remains to be investigated. However, in PSS the aberrant production of these 2 fibroblast proliferation inhibito ry factors did occur in t he presence of t he production of normal levels of both the MK stimulating fibroblast proliferation and the LK and MK inhibiti ng fibroblast collagen production (Fig 3) .
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While the mechanisms responsibl e for the observed aberran t production of both T cell -derived and monocyte-derived proliferatio n inhibi to ry factors likely involve t he complex in teraction of c ells and mediators regulating the LK/ MK cascade, rece nt reports suggest 2 plausible, although possibly simplified, explanati o ns. Firstly, a number of studies suggest t hat the increased B -cell fun ction associated wi t h autoantibody formation in PSS may be t he resul t of a deficiency of circul ating T suppressor ce ll s [30] [31] [32] . Since T suppressor cells are a likely source of our prolifera tion inhibitory LK, t hen a deficiency ofT suppressor cells could expl ain why we have observed a deficient production of th is LK in PSS patients. Secondly, other studies have suggested t hat t he depressed T -cell functions associated with PSS may be the resul t of t he increased activity of suppressor monocytes [33, 34] . These hyp eractive suppressor monocytes may be t he source of the increased levels of the proliferation inhibitory MK produced by a port ion of our PSS patients. Such s uppressor monocytes have also been described in murine models of graft-versus-host disease, where they were associated o nly with t he later stages of t he disease [52 ] . Whether suppresso r monocytes ar e present only in PSS pat ients of long duration has not been in vestigated, but this may be t he case if our results are indicative of increased suppressor monocyte activity, as all the PSS pati ents we studied had a disease duration of 3 years or more with a group mean of 9.6 years.
A ss uming that t he production of LK/ MK in PSS tissue sites para llels t hat which we have observed with peripheral blood MNL, then our results suggest t hat t he increased fibroblast popu lation seen in early PSS tissue sites is due to t he deticient p r oduction of a fibroblas t p roliferation inhibi tory LK, allowing excess fibr oblast-growth stimulatory signals to unrestrictedly expand t he resident fibroblast population . In vivo, the growthstimulating signals may include not only stimulatory LK and MK, but also platelet-derived growth factor (PDGF) as studies s u ggest that the vascular endothelial damage occurring in PSS results in the perivascul ar aggregation of platelets and the subsequent discharge of PDGF into PSS tissue sites [53 ] . Our res ults fu rt her suggest t hat t he increased fibroblast growth cau sed by t his relative excess of fibroblast-proliferation stimulatory signal s is moderated in long-term PSS patients by the increased production of a fibrobl ast-growth inhibitory MK S u c h a mechani sm would play a role in limit in g previously init iated fibrosis and could be responsible for t he more stabilized forms of PSS often seen in long-term patients. Proof of t his theory, however , requires investigation of t he levels of fibroblast proliferation inhibitory LK/ MK produced by pat ients with newly acquired PSS.
Our results also show that t he production of t he LK and MK inhibiting fibroblast collagen production is normal and thus t hese 2 factors ca nn ot be implicated in t he induction of the portion of PSS fibrob lasts which possess a hyper-collage nproducing phenotype. However, other studies suggest t hat this phenotyp ic change may be caused by t he excessive production of a co llage n production stimulatory LK by PSS MNL [54, 55) or, a lte rnatively, t hose fibroblasts t hat have been induced to pro liferate by t he relative excess of PDGF may innately possess t he hyper-collagen -producing phenotype [56 ] . Thus both t he increased fibroblast number and the increased fibroblast function observed in PSS tissue sites appea r to be t he result of system ic immun ologic a bnormali t ies exacerbating a n in situ i.nflammatory response by causin g t he unbalanced production of stimulatory and inhibito ry fibroblas t -regulatory LK/ MK We wou ld like to t ha nk Ms. Vilma Ca rt·e r for tec hni cal assista nce in pe rfo rmin g th is st.udy a nd Ms. Kay Feick a nd Mrs. Ma rga ret Prind le for sec reta ri a l assista nce in prepa rin g thi s man usc ript..
